Summary & Overview
HCPCS P3001: Screening Papanicolaou Smear, Cervical or Vaginal
HCPCS Level II code P3001 represents a screening Papanicolaou (Pap) smear of the cervix or vagina, up to three smears, with interpretation by a physician. As a widely used preventive service in women's health, this code supports cervical cancer screening programs and informs quality measurement and coverage decisions at the national level. Its use affects preventive care access, lab utilization, and clinical workflow for outpatient and ambulatory gynecologic services.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for cervical/vaginal cytology, typical sites of service, and payer coverage patterns. The publication summarizes benchmarks for utilization and reimbursement where available, notes relevant policy and coverage trends affecting screening services, and outlines coding considerations tied to service delivery in outpatient settings.
This summary is intended for health policy analysts, revenue cycle managers, and clinical leaders seeking a national-level briefing on HCPCS Level II code P3001, its role in preventive care, and the payer landscape that shapes access and billing for Pap smear screening.
Billing Code Overview
HCPCS Level II code P3001 describes a screening Papanicolaou (Pap) smear, cervical or vaginal, up to three smears, requiring interpretation by a physician. This service involves collection of cellular specimens from the cervix and/or vagina for cytologic evaluation.
Service Type: Screening cervical/vaginal cytology
Typical Site of Service: Outpatient clinic, primary care office, women's health clinic, or gynecology office
Clinical & Coding Specifications
Clinical Context
A 29-year-old female presents to an outpatient gynecology clinic for routine cervical cancer screening. She is asymptomatic, sexually active, and due for her routine Pap test per age-based screening guidelines. The medical assistant rooming the patient documents contraceptive use, menstrual history, and last screening date. A single-use speculum exam is performed; a clinician obtains cervical cytology samples (up to three separate smears if needed) using a spatula, cytobrush, or broom device and places specimens on slides or into liquid-based cytology vials. The specimens are labeled and sent to the pathology laboratory. The physician or qualified health professional performs microscopic interpretation and issues a formal cytology report. Typical documentation includes indication for screening, method of collection, number of smears or vials collected, anatomical source (cervix and/or vagina), any clinician-perceived difficulty, and the interpretive findings from the pathologist. Billing uses HCPCS Level II code P3001 to represent a screening Papanicolaou smear, cervical or vaginal, up to three smears, when interpretation is performed by a physician. Typical site of service is an outpatient clinic, physician office, or community health center. The scenario may also occur in family planning clinics or gynecologic preventive care visits.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component |